ROCKVILLE, Md., April, 26, 2017
/PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a
late-stage clinical company developing therapeutics that preserve
the microbiome to protect and restore the health of patients,
announced today that the Company intends to release its operational
highlights and financial results for the quarter ended March 31, 2017 on Thursday, May 4, 2017, and to host a conference
call the same day at 4:30 p.m. EDT.
The dial-in information for the call is as follows:
U.S. (toll free): 1-888-347-5280
International: +1 412-902-4280
Participants are asked to dial in 15 minutes before the start of
the call to register. The call will also be webcast over the
Internet at https://www.webcaster4.com/Webcast/Page/1096/20882. An
archived replay of the call will be available for approximately
ninety (90) days at the same URL,
https://www.webcaster4.com/Webcast/Page/1096/20882, beginning
approximately one hour after the call's conclusion.
About Synthetic Biologics, Inc.
Synthetic Biologics,
Inc. (NYSE MKT: SYN) is a late-stage clinical company developing
therapeutics designed to preserve the microbiome to protect and
restore the health of patients. The Company's lead candidates
poised for Phase 3 development are: (1) SYN-010 which is intended
to reduce the impact of methane producing organisms in the gut
microbiome to treat an underlying cause of irritable bowel syndrome
with constipation (IBS-C), and (2) SYN-004 (ribaxamase) which is
designed to protect the gut microbiome from the effects of certain
commonly used intravenous (IV) beta-lactam antibiotics for the
prevention of C. difficile infection (CDI),
antibiotic-associated diarrhea (AAD) and the emergence of
antimicrobial resistance (AMR). The Company is also developing
preclinical stage monoclonal antibody therapies for the prevention
and treatment of pertussis and novel discovery stage
biotherapeutics for the treatment of phenylketonuria (PKU). For
more information, please visit Synthetic Biologics' website at
www.syntheticbiologics.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/synthetic-biologics-to-report-first-quarter-2017-operational-highlights-and-financial-results-on-may-4-2017-300446512.html
SOURCE Synthetic Biologics, Inc.